COVID-19: the endocrine opportunity in a pandemic.


Journal

Minerva endocrinologica
ISSN: 1827-1634
Titre abrégé: Minerva Endocrinol
Pays: Italy
ID NLM: 8406505

Informations de publication

Date de publication:
Sep 2020
Historique:
pubmed: 18 6 2020
medline: 9 10 2020
entrez: 18 6 2020
Statut: ppublish

Résumé

The 2019 Coronavirus disease (COVID-19) pandemic has disrupted the social, economical and medical system worldwide. Although it is strictly an infectious disease, its intricate bidirectional relationship with various non-communicable metabolic diseases and endocrinological factors has been observed. While diabetes, hypertension, obesity have been found to be independent risk factors for COVID-19 disease severity and mortality, more inclination towards sedentary lifestyle, psychosocial stress at this critical time may be the harbingers of metabolic syndrome. Thus, endocrinologists have a great opportunity to play their role to combat this pandemic. This paper examines how various endocrinological disorders influence the dynamics of COVID-19 and vice versa. Moreover, it also intends to review the clinical guidelines to be adopted in practice of endocrinology in this trying time.

Identifiants

pubmed: 32548995
pii: S0391-1977.20.03216-2
doi: 10.23736/S0391-1977.20.03216-2
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

204-227

Auteurs

Subhankar Chatterjee (S)

Department of General Medicine, Rajendra Institute of Medical Sciences, Ranchi, India - chatterjeeaspiresubhankar.92@gmail.com.

Ritwik Ghosh (R)

Department of General Medicine, Burdwan Medical College and Hospital, Burdwan, India.

Payel Biswas (P)

Department of Radiodiagnosis, Care and Cure Hospital, Barasat, India.

Souvik Dubey (S)

Department of Neuromedicine, Bangur Institute of Neurosciences, Institute of Post Graduate Medical Education and Research and SSKM Hospital, Kolkata, India.

Rishi T Guria (RT)

Department of General Medicine, Rajendra Institute of Medical Sciences, Ranchi, India.

Chandra B Sharma (CB)

Department of General Medicine, Rajendra Institute of Medical Sciences, Ranchi, India.

Sanjay Kalra (S)

Department of Endocrinology, Bharti Hospital, Karnal, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH